CA
15
6
TXT
70
-2
AMT
39
3
HPQ
37
6
ED
50
-9
LOW
24
-4
MAS
34
-4
NWL
39
-2
MLM
50
2
CI
45
2
AMGN
39
-5
FRT
45
2
EQR
25
5
VFC
59
-2
PCAR
56
11
IBM
67
3
FE
62
2
AAL
16
-13
ADBE
44
3
COF
47
-3
CA
15
6
TXT
70
-2
AMT
39
3
HPQ
37
6
ED
50
-9
LOW
24
-4
MAS
34
-4
NWL
39
-2
MLM
50
2
CI
45
2
AMGN
39
-5
FRT
45
2
EQR
25
5
VFC
59
-2
PCAR
56
11
IBM
67
3
FE
62
2
AAL
16
-13
ADBE
44
3
COF
47
-3
Financhill
Back

Innovent Biologics, Inc. 10K Form

Buy
80

IVBXF
Innovent Biologics, Inc.

Last Price:
$11.72
Seasonality Move:
32.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IVBXF News And Ratings

See the #1 stock for the next 7 days that we like better than IVBXF

IVBXF Financial Statistics

Sales & Book Value

Annual Sales: $1.8B
Cash Flow: $0
Price / Cash Flow: 141.95
Annual Sales: $1.10
Price / Book: 10.65

Profitability

EPS (TTM): 0.06440
Net Income (TTM): $112.1M
Gross Margin: $1.6B
Return on Equity: -0.75%
Return on Assets: -0.46%

Innovent Biologics, Inc. Earnings Forecast

Key Innovent Biologics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 10 years for IVBXF is 86.54%.
  • The Selling, General & Administrative Expenses for IVBXF have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 20.12% of Revenue.
  • The Interest Expense is 9.78% of Operating Income.
  • The Net Earning history of IVBXF is 6.24% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 6 years.

Innovent Biologics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: IVBXF
Website: innoventbio.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 2.35
Quick Ratio: 2.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IVBXF Technical Analysis vs Fundamental Analysis

Buy
80
Innovent Biologics, Inc. (IVBXF) is a Buy

Is Innovent Biologics, Inc. a Buy or a Sell?